BarryReisbergMD

Dementia, Clinical Pharmacology

Professor, Department of Psychiatry Clinical Dir Aging & Dementia Rsch Ctr Director of the Zachary and Elizabeth M. Fisher Alzheimer Disease Education and Research program NYU School of Medicine

Join to view full profile

Dr. Reisberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reisberg's full profile

Already have an account?

Office
20 Waterside Plz
Apt 7K
New York, NY 10010
Phone+1 212-889-7579

Fax+1 212-263-6991

Summary

Barry Reisberg, M.D. is a Professor of Psychiatry at NYU Langone Health and Adjunct Professor at the Centre for Studies in Aging, McGill University, Montreal, Canada. Dr. Reisberg has directed research which has significantly advanced current understanding and treatment of Alzheimer's disease (AD). He was the first to describe many of the most important symptoms of AD and the characteristic clinical course of AD. His staging tools are presently governmentally mandated measures throughout the U.S., and widely used worldwide.

Dr. Reisberg’s work has been instrumental in the development of all major current pharmacological treatment modalities for AD, i.e., memantine, treatment for behavioral disturbances in dementia (e.g., risperidone), rivastigmine for mild to moderate dementia, and donepezil for severe dementia.

Dr. Reisberg and his associates developed the concepts behind and coined the terminology, “mild cognitive impairment,” a now universally recognized entity. His descriptions of an even earlier clinically manifest stage - “subjective cognitive impairment,” are increasingly being recognized as the earliest manifestations of AD in seemingly normal persons. Dr. Reisberg’s description of the retrogenic neurodevelopmental process in AD and related dementias is also advancing a new science of AD management and providing new insights into AD etiopathogenesis. In a 2017 study, Dr. Reisberg, et al. have demonstrated that a comprehensive management program can provide 10 times the benefits of either current AD medications or traditional non-pharmacologic treatments.

Dr. Reisberg has been the recipient of numerous awards for his pioneering research including a Lifetime Achievement Award for Research in Alzheimer’s disease. He is a Distinguished Life Fellow of the American Psychiatric Association. He has also served as President of the International Psychogeriatric Association, and is a Fellow of the American College of Neuropsychopharmacology.

Education & Training

New York Medical College (Metropolitan)Residency, Psychiatry, 1973 - 1975
Lincoln Medical and Mental Health CenterInternship, Transitional Year, 1972 - 1973
New York Medical CollegeClass of 1972
Brooklyn CollegeBA, 1964 - 1968
Nasson CollegeNo Degree, 1963

Certifications & Licensure

NY State Medical License 1973 - 2023
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Geriatric Psychiatry

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2001-2016, 2020
Best Doctors in America, Woodward/White The Best Doctors in America
Jack Weinberg Memorial Award for Geriatric Psychiatry American Psychiatric Association, 2017
Top Doctors: New York Metro Area Castle Connolly, 2002-2017
New York Metro Top Doctors for 15 Year Castle Connolly Medical Ltd., 2016
Super Doctors New York Hall of Fame Super Doctors, 2016
Distinguished Life Fellow American Psychiatric Association, 2015
Dean's Honor Day New York University School of Medicine, 2012, 2015
New York Magazine: Top Doctors Castle Connolly, 1996, 1998-2013
Honorary Member Alzheimer's and related disorders society of India, 1994-2013
Top Doctor for 15 Years New York Magazine, Castle Connolly Medical Ltd., 2012
Historic Work in the development of Neuropsychopharmacology highlighted and described American College of Neuropsychopharmacology, "An oral history of neuropsychopharmacology: the first 50 years", 2011
Mano Amiga Award Association of Family Members of People with Alzheimer's, Leon, Spain, 2011
New York Metro Area Top Doctors: Ten Years in a Row Castle Connolly Medical Ltd., 2011
America's Top Doctor's:Ten Years in a Row Castle Connolly Medical Ltd., 2011
Distinguished Scientist Award American Association for Geriatric Psychiatry, 2011
Annual Barry Reisberg Award Lecture Hearthstone Alzheimer's Family Foundation and Forest Laboratories, 2002-2011
Life Fellow American Psychiatric Association, 2009
America's Top Psychiatrists Consumer Research Council of America, 2008
Fellow American Psychiatric Association, 2005
Visiting Professor in Geriatrics Stonybrook University Health Sciences Center, 2005
Fellow American Aging Association, 2005
Visiting Professor, Georgetown University Medical Center Frank Brenda Alzheimer's Fund, Washington DC, 2004
Lifetime Achievement Award in Recognition of Outstanding Research, Alzheimer's Association, 2004
Award for Distinguished Service International Psychogeriatric Association, 2001
First Annual Bayer Visiting Professor Award St. Louis University School of Medicine, 1999
Best Mental Health Experts Good Housekeeping, 1994
Visiting Professor Palmerston North Postgraduate Medical Society, New Zealand, 1991
Home Care Award Visiting Nurse Service of New York, 1985
Diplomat American Board of Psychiatry and Neurology, 1976
Diplomat National Board of Medical Examiners, 1973
Japan Society Fellowship Council on International Education Exchange, 1968
US News and World Report Top Doctors U.S. News and World Report, 2011
New York Super Doctors superdoctors.com, 2008
Who's Who in the World 2006
New York Metro Area Top Doctors Castle Connolly Medical Ltd., 2002
The Best Doctors in New York New York Magazine, 1996
Who's Who in America 1990
Special Initiative Award for Research on Aging National Institute on Aging, US National Institutes of Health, 1979
Physician's Recognition Awards in Continuing Medical Education American Medical Association, 1976
New York State Regents Scholarship 1964
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training Start of enrollment: 2006 Aug 01
Completed
Phase 4
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome Start of enrollment: 2016 Jul 01
Completed
A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol Start of enrollment: 2009 Jun 18
Terminated
Phase 1

Publications & Presentations

PubMed

1781 citations
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen, Rebecca E. Amariglio, Martin P.J. van Boxtel, Monique M.B. Breteler, Mathieu Ceccaldi
Alzheimer's & Dementia. 2014-11-01
143 citations
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.
Adam C. Naj, Gyungah Jun, Christiane Reitz, Brian W. Kunkle, William Perry
JAMA Neurology. 2014-11-01
623 citations
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims, Sven J. van der Lee, Adam C. Naj, Céline Bellenguez, Nandini Badarinarayan
Nature Genetics. 2017-09-01

Journal Articles

Rarity of the Alzheimer disease-protective APP A673T variant in the United States
335. Wang, L-S., Naj, A.C., Graham, R.R., Crane, P.K., Kunkle, B.W., Cruchaga, C., Gonzalez Murcia, J.D., Cannon-Albright, L., Baldwin, C.T., Zetterberg, H., Blennow, ..., JAMA Neurology, 2015
A Novel Alzheimer Disease Locus Located near the Gene Encoding Tau Protein
Jun, G., Ibrahim-Verbaas, C.A., Vronskaya, M., Lambert, J-C., Chung, J., Naj, A.C., Kunkle, B.W., Wang, L-S., Bis, J-C., Bellenguez, C., Harold, D., Lunetta, K.L., Des..., Molecular Psychiatry, 1/1/2015
Subjective Cognitive Decline in Older Adults: An Overview of Self-report Measures Used across 19 International Research Studies
Rabin, L.A., Smart, C.M., Crane, P.K., Amariglio, R.E., Berman, L.M., Boada, M., Buckley, R.F., Chetelat, G., Dubois, B., Ellis, K.A., Gifford, K.A., Jefferson, A.L, J..., Journal of Alzheimer's Disease, 1/1/2015
Association of MAPT Haplotypes with Alzheimer's Disease Risk and MAPT Brain Gene Expresasion Levels
Allen, M., Kachadoorian, M., Quicksall, Z., Zou, F., Chai, H.S., Younkin, C., Crook, J.E., Pankratz, V.S., Carrasquillo, M.M., Krishnan, S., Nguyen, T., Ma, L., Malphr..., Alzheimer's Research and Therapy, 1/1/2014
Effects of Multiple Genetic Loci on Age at Onset in Late-onset Alzheimer Disease: A Genome-wide Association Study
Naj, A.C., Jun, G., Reitz, C., Kunkle, B.W., Perry, W., Park Y.S., Beecham, G.W., Rajbhandary, R.A., Hamilton-Nelson, K.L., Wang, L-S., Kauwe, J.S.K., Huentelman, M.J...., JAMA Neurology, 1/1/2014
GWAS of Cerebrospinal Fluid Levels Identifies Risk Variants for Alzheimer's Disease
Cruchaga, C., Kauwe, J.S.K., Harari, O., Jin, S.C., Cai, Y., Karch, C.M., Benitez, B., Jeng, A. T., Skorupa, T., Carrell, D., Bertelsen, S., Bailey, M., McKean, D., Sh..., Neuron, 1/1/2013
Initial Assessment of the Pathogenic Mechanisms of The Recently Identified Alzheimer Risk Loci
Holton, P., Ryten, M., Nalls, M., Trabzuni, D., Weale, M.E., Hernandez, D., Crehan, H., Gibbs, J.R., Mayeux, R., Haines, J.L., Farrer, L.A., Pericak-Vance, M.A., Schel..., Annals of Human Genetics, 1/1/2013
Reitz, C., Jun, G., Naj, A., Rajbhandary, R., Vardarajan, B.N., Wang, L-S., Valladares, O., Lin, C-F., Larson, E.B., Graff-Radford, N.R., Evans, D., De Jager, P.L., Cr..., The Journal of the American Medical Association, 1/1/2013
Meta-analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer's Disease
Lambert, J.-C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., Jun, G., DeStefano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G..., Nature Genetics, 1/1/2013
SORL1 Is Genetically Associated with Late-onset Alzheimer's Disease in Japanese, Koreans and Caucasians
Miyashita, A., Koike, A., Jun, G., Wang, L-S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M.,Tomita, N., Arai, H., Asada, T., Harigaya, Y., Ikeda, M., Ama..., PLoS One, 1/1/2013
Independent and Epistatic Effects of Variants in VPS10-d Receptors on Alzheimer Disease Risk and Processing of the Amyloid Precursor Protein (APP)
Reitz, C., Tosto, G., Vardarajan, B., Rogaeva, E., Ghani, M., Rogers, R.S., Conrad, C., Haines, J.L., Pericak-Vance, M.A., Fallin, M.D., Foroud, T., Farrer, L.A., Sche..., Translational Psychiatry, 1/1/2013
Independent and Epistatic Effects of Variants in VPS10-d Receptors On Alzheimer Disease Risk and Processing of the Amyloid Precursor Protein (APP)
Reitz, C., Mayeux, R., Albert, M.S., Albin, R.L., Apostolova, L.G., Arnold, S.E., Baldwin, C.T., Barber, R., Barmada, M.M., Barnes, L.L., Beach, T.G., Beecham, G.W., B..., The New England Journal of Medicine, 1/1/2013
Alzheimer's Disease: Analyzing the Missing Heritability
Ridge, P.G., Mukherjee, S., Crane, P.K., Kauwe, J.S., Albert, M.S., Albin, R.L., Apostolova, L.G., Arnold, S.E., Baldwin, C.T., Barber, R., Barmada, M.M., Barnes, L.L...., PLoS One, 1/1/2013
Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-associated Variants
Zou, F., Chai, H.S., Younkin, C.S., Crook, J., Pankratz, V.S., Allen, M., Carrasquillo, M.M., Rowley, C.N., Nair, A.A., Middha, S., Maharjan, S., Nguyen, T., Ma, L., M..., PLoS Genetics, 1/1/2012
Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region
Jun, G., Vardarajan, B.N., Buros, J., Yu, C.-E., Hawk, M.V., Dombroski, B.A., Crane, P.K., Larson, E.B., Apostolova, L.G., Arnold, S.E., Baldwin, C.T., Barmada, M.M., ..., Archives of Neurology, 1/1/2012
Novel Late-onset Alzheimer Disease Loci Variants Associate with Brain Gene Expression
Allen, M., Zou, F., Chai, H.S., Younkin, C.S., Crook, J., Pankratz, V.S., Carrasquillo, M.M., Rowley, C.N., Nair, A.A., Middha, S., Maharjan, S., Nguyen, T., Ma, L., M..., Neurology, 1/1/2012
Link between DYRK1A Overexpression and Several-fold Enhancement of Neurofibrillary Degeneration with 3-repeat Tau Protein in down Syndrome
Wegiel, J., Kaczmarski, W., Barua, M., Kuchna, I., Nowicki, K., Wang, K.-C., Wegiel, J., Ma, S.Y., Frackowiak, J., Mazur-Kolecka, B., Silverman, W.P., Reisberg, B., Mo..., Journal of Neuropathology and Experimental Neurology, 1/1/2011
A Retrogenic Model for Detecting Abuse of Institutionalized People with Alzheimer's Disease
Romanian Journal of Bioethics, 1/1/2011
The Concept of Retrogenesis in Alzheimer's Disease: Ethical and Forensic Implications
Romanian Journal of Bioethics, 1/1/2011
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Alzheimer's Disease and Other Dementias
Ihl, R., Frolich, L., Winblad, B., Schneider, L., Burns, A., Moller, H.-J., Blesa, R., Brodaty, H., Dartigues, J.-F., Degrell, I., DeKosky, S., Endo, H., Erkinjjuntti,..., World Journal of Biological Psychiatry, 1/1/2011
Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions with APOE Genotypes
Jun, G., Naj, A.C., Beecham, G.W., Wang, L-S., Buros, J., Gallins, P.J., Buxbaum, J.D., ErtekinTaner, N., Fallin, M.D., Friedland, R., Inzelberg, R., Kramer, P., Rogae..., Archives of Neurology, 1/1/2010
A Roadmap for the Prevention of Dementia II Leon Thal Symposium 2008
Khachaturian, Z.S., Snyder, P.J., Doody, R., Aisen, P., Comer, M., Dwyer, J., Frank, R.A., Holzapfel, A., Khachaturian, A.S., Korczyn, A.D., Roses, A., Simpkins, J.W.,..., Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 1/1/2009
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients with Mild Alzheimer Disease: A Randomized Controlled Trial
Green, R.C., Schneider, L.S., Amato, D.A., Beelen, A.P., Wilcock, G., Swabb, E.A., Zavitz, K.H., Aaronson, S., Adler, L., Aisen, P., Alva, G., Antuono, P., Apter, J., ..., The Journal of the American Medical Association, 1/1/2009
An Interview with Barry Reisberg, MD
Ashraf, N., The Residents' Journal, 1/1/2009
Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): validacion espanola
Boada, M., Tarraga, L., Modinos, G., Diego, S., Reisberg, B., Neurologia, 1/1/2006
Join now to see all

Books/Book Chapters

Care Giving for Alzheimer's Disease: A Compassionate Guide for Clinicians and Loved Ones
Chapter: Foreword
Reisberg, B.Editors: Carson, V.B., Vanderhorst, K.J. and Koenig, H.G..Springer2015
An Oral History of Neuropsychopharmacology: The First Fifty Years: Peer Interviews
Page 385.0 - 401.0Reisberg, B.Editors: Thomas A. Ban (editor), Barry Blackwell (volume editor).American College of Neuropsychopharmacology, Brentwood, Tennessee2011
Heuristic Modeling of the Mental Progress of Persons with Normal Brain Aging, Subjective Cognitive Impairment, Mild Cognitive Impairment, Alzheimer's Disease, and Related Dementia Disorders.
Page 167.0 - 172.0Winkler, S., Auer, S., Affenzeller, M., Donabauer, Y., and Reisberg, B.Editors: Claudia Frydman, Francesco Longo, and Khalid Mekouar.Universidad de la Laguna2009
Handbook of Psychiatric Measures
Chapter: The GDS Staging System: Global Deterioration Scale (GDS), Brief Cognitive Rating Scale (BCRS), Functional Assessment Staging (FAST).
Page 431.0 - 435.0Reisberg, B., Sclan, S., Franssen, E., de Leon, M.J., Kluger, A., Torossian, C., Shulman, E., Steinberg, G., Monteiro, I., McRae, T., Boksay, I., Mackell, J. Ferris, S.H.Editors: A.J. Rush, Jr., M.B. First, and D. Blacker.American Psychiatric Publishing, Washington, D.C.Edition Seco,2008
Diagnostic Issues in Dementia: Advancing the Research Agenda for DSM-V
Chapter: Diagnostic Criteria in Dementia: A Comparison of Current Criteria, Research Challenges, and Implications for DSM-V
Page 27.0 - 50.0Reisberg, B. and Sartorius, N.Editors: T. Sunderland, D.V. Jeste, O. Baiyewu, P. J. Sirovatka, and D.A. Regier.American Psychiatric Association, Arlington, Virginia2007
Severe Dementia
Chapter: Clinical Features of Severe Dementia: Staging.
Page 83.0 - 115.0Reisberg, B., Wegiel, J., Franssen, E., Kadiyala, S., Auer, S., Souren, L., Sabbagh, M., Golomb, J.Editors: A. Burns and B. Winblad.John Wiley & Sons, London2006
Alzheimer's Disease: New Advances
Chapter: Behavioral and Neuropathophysiologic Course of Alzheimer's Disease (AD): A Synthesis Based on Retrogenesis, Arboreal and Neurometabolic Entropy and Possible Etiopathogenic Events.
Page 219.0 - 222.0Reisberg, B., Wegiel, J., Franssen, E., Auer, S., Shimada, M., Meguro, K., Kadiyala, S., Borza, L.Editors: K. Iqbal, B. Winblad, and J. Avila.Medimond International Proceedings, Bologna (Italy)2006
Medical Aspects of Disability
Chapter: Alzheimer's Disease
Page 79.0 - 118.0Reisberg, B., Javed, A., Kenowsky, S., Auer, S.R.Editors: H.H. Zaretsky, E.F. Richter III, M.G. Eisenberg.Springer, New YorkEdition 3rd,2005
Guide to Assessment Scales in Dementia.
Chapter: Clinician's Interview-Based Impression of Change-Plus.
Page 9.0 - 21.0Reisberg, B., Ferris, S.H.Editors: C. Kelly, G. Newton-Howes.Science Press Ltd., London, U.K.2004
Comprehensive Textbook of Geriatric Psychiatry
Chapter: Alzheimer's Disease.
Page 449.0 - 509.0Reisberg, B., Saeed, M.U.Editors: J. Sadovoy, L.F. Jarvik, G.T. Grossberg and B. S. Meyers.W.W. Norton, New York (NY)2004
Dementia: Presentations, Differential Diagnosis and Nosology
Chapter: The Neuropathology of Alzheimer Dementia.
Page 89.0 - 120.0Wegiel, J., Wisniewski, T., Reisberg, B., Silverman, W.Editors: V.O. B. Emery, T.E. Oxman.Johns Hopkins University Press, BaltimoreEdition Seco,2003
Encyclopedia of Aging
Chapter: Retrogenesis
Page 1222. - 1225.Reisberg, B., Gondotra, G., Kenowsky, S., Franssen, E.Editors: D.J. Ekerdt, R. Applebaum, K.C. Holden, S.G. Post, K. Rockwood, R. Schultz, R.L. Sprott, and P. Uhlenberg.Macmillan Reference USA, New York2002
WPA Series: Evidence and Experience in Psychiatry
Chapter: Clinical Diagnosis of Dementia: A Review.
Page 69.0 - 115.0Reisberg, B., Franssen, E., Shah, M.A., Weigel, J., Bobinski, M., Wisniewski, H.M.Editors: M.Maj and N. Sartorius.John Wiley and Sons, Chichester, West SussexEdition Seco,2002
Principles and Practice of Geriatric Psychiatry
Chapter: Prognosis of Dementia.
Page 308.0 - 312.0Reisberg, B., Kluger, A., Franssen, E.Editors: J.R.M. Copeland, M.T. Abou-Saleh, D. G. Blazer.John Wiley, Chichester (UK)Edition 2nd,2002
Principles and Practice of Geriatric Psychiatry
Chapter: International Psychogeriatric Association (IPA)
Reisberg, B. (former IPA President), Finkel, F.F. (Executive Director)Editors: J.R.M. Copeland, M.T. Abou-Saleh, D.G. Blazer.John Wiley, Chichester (UK)Edition 2nd,2002
Principles and Practice of Geriatric Psychiatry
Chapter: Staging Dementia
Page 142.0 - 145.0Reisberg, B., Gondotra, G., Zaidi, A., Ferris, S.H.Editors: J.R.M. Copeland, M.T. Abou-Saleh, D.G. Blazer.John Wiley, Chichester (UK)Edition 2nd,2002
Vascular Cognitive Impairment
Chapter: Staging: Relevance for Trial Design in Vascular Burden of the Brain
Page 557.0 - 569.0Reisberg, B., Ferris, S.H., Oo, T., Franssen, E.Editors: T. Erkinjuntti, S. Gauthier.Martin Dunitz, London2002
Kaplan & Sadock's Pocket Handbook of Clinical Psychiatry
Sadock, B.J. and Sadock, V.A.Lippincott Williams and Wilkins, PhiladelphiaEdition Thir,2001
International Encyclopedia of the Social and Behavioral Sciences
Chapter: Dementia Overview.
Page 3389. - 3396.Reisberg, B.Editors: N.J. Smelser, P.B. Baltes.Elsevier Science, Oxford (UK)2001
Handbook of Psychiatric Measures
Chapter: Global Deterioration Scale (GDS), Brief Cognitive Rating Scale (BCRS) and Functional Assessment Staging (FAST) Measures: The GDS Staging System.
Page 450.0 - 455.0Reisberg, B., Ferris, S.H.Editors: American Psychiatric Association Task Force for the Handbook of Psychiatric Measures.American Psychiatric Association, Washington (DC)2000
World Psychiatric Association Series: Evidence and Experience in Psychiatry
Chapter: Clinical Diagnosis of Dementia: A Review
Page 69.0 - 115.0Reisberg, B., Franssen, E., Shah, M.A., Weigel, J., Bobinski, M., Wisniewski, H. M.Editors: M. Maj and N. Sartorius.John Wiley & Sons, Chichester2000
Handbook of Psychiatric Measures
Chapter: Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD).
Page 401.0 - 404.0Reisberg, B., Borenstein, J., Salob, S.P., Ferris, S.H., Franssen, E., Georgotas, A.Editors: American Psychiatric Association Task Force for the Handbook of Psychiatric Measures.American Psychiatric Association, Washington (DC)2000
An Atlas of Alzheimer's Disease
Chapter: Clinical Stages of Alzheimer's Disease
Page 11.0 - 20.0Reisberg, B., Franssen, E.H.Editors: M.J. de Leon.Parthenon, Carnforth (UK)1999
Clinical Diagnosis and Management of Alzheimer's Disease
Chapter: Abnormal Behavior in Alzheimer's Disease.
Page 197.0 - 212.0Eastwood, R., Reisberg.Editors: S. Gauthier.Martin Dunitz, LondonEdition 2nd,1999
Health Economics of Dementia
Chapter: Severity Scales.
Page 327.0 - 357.0Reisberg, B., Franssen, E., Souren, L., Kenowsky, S., Auer, S.Editors: A. Wimo, B. Jonsson, G. Karlsson, and B. Winblad.John Wiley and Sons, Chichester1998
Join now to see all

Abstracts/Posters

Evidence for Affective Symptoms as an Early Manifestation of Cognitive Change
Guillo-Benarous, F., Sidhu, J., Patel, P., Naqvi, S., Thu, M., Ghimire, S., Xu, J., and Reisberg, B., Neurodegenerative Diseases, 1/1/2015
Mock Trial of a Lawsuit Alleging Financial Fraud Against a 79 Year Old Woman by an Insurance Agent and an Insurance Company
Stein, E.M., Finkel. S., Liptzin, B., Reisberg, B., The American Journal of Geriatric Psychiatry, 1/1/2014
Evaluation of Symptoms in Persons with Subjective Cognitive Impairment
Guillo-Benarous, F., Vengassery, A., Ghimire, S., Xu, J., Torossian, C., and Reisberg, B., Alzheimer's & Dementia, 1/1/2014
One Year Global Outcome of a Comprehensive, Individualized, Person Centered Management (CI-PCM) Program + Memantine in Advanced AD: A Randomized Controlled Trial
Reisberg, B., Boksay, I., Golomb, J., Agarwal, S., Ghimire, S., Shaker, S., Torossian, C., Xu, J., and Kenowsky, S., Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 1/1/2014
Treatment of Normal Older Persons with Subjective Cognitive Impairment (SCI) With Neurogenesis Enhancer, Antiamyloid Medications: Initial 2 Year Electrophysiologic Obs...
Reisberg, B., Cerbone, B., Ghimire, S., Oo, T., Patel, P., Hoover, G., and Prichep, L., Neuropsychopharmacology, 1/1/2014
A Mock Trial of a Will Contest of a Cognitively Impaired 85-year Old Woman
Finkel, S.I., Reisberg, B., Liptzin, B., Shulman, K., Luxenberg, J., and Stein, E., American Association for Geriatric Psychiatry's 2013 Annual Meeting, Final Program, 1/1/2013
Memantine and Comprehensive, Individualized, Person Centered Management (CI-PCM) Of Alzheimer's Disease: A Randomized Controlled Trial
Reisberg, B., Kenowsky, S., Boksay, I., Golomb, J., Heller, S., Ghimire, S., Salam, M., Qureshi, S., Kumar, M., Torrosian, C., and Vedvyas, A., Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 1/1/2013
Addition of a Comprehensive, Individualized, Person Centered Management Program, to Memantine Alone Produces a 900% Increment in a Pivotal Trial Global Measure over Me...
Reisberg, B., Kenowsky, S., Heller, S., Boksay, I., Golomb, J., Ghimire, S., Torossian, C., Lobach, I., Neuropsychopharmacology, 1/1/2013
Remission of Pre-mild Cognitive Impairment (MCI), Subjective Cognitive Impairment (SCI): A Two Year Prospective Study of Demographic and Behavioral Markers
Reisberg, B., Osorio, R., Khan, A., Torossian, C., Roy, K., Boksay, I., Thwin, O., Khanzada, N., Kumar, P., Shulman, M., and Lobach, I., Alzheimer's & Dementia, 1/1/2012
Screeening Performance of the Healthy Brain Checklist in a Community Setting
Shankle, W., Fortier, D., Hara, J., Keeble, C., Macias, D., Holnagel, D., Brandt-Zawadzki, M., and Reisberg, B., Alzheimer's & Dementia, 1/1/2012
Relating Memory to Functional Activities in Normal Aging, Alzheimer's Disease and Related Disorders Using Hierarchical Bayesian Cognitive Processing Models
Pooley, J., Shankle, W., Hara, J., Reisberg, B., and Lee, M., Alzheimer's & Dementia, 1/1/2012
Subjective Cognitive Impairment, the Pre-mild Cognitive Impairment Stage of Eventual Alzheimer's Disease: Prospective Behavioral Markers of 2 Year Decline
Reisberg, B., Torossian, C., Osorio, R., Ghimire, S., Roy, K., Sharma, P., Monteiro, I., Shulman, M.B., and Lobach, I., Neuropsychopharmacology, 1/1/2012
Workshop on Methodologies for Clinical Trials in Pre-MCI Persons with Subjective Cognitive Impairment (SCI)
Reisberg, B., Rockwood, K., and Sadovoy, J., 26th International Conference of Alzheimer's Disease International, Programme and Abstract Booklet, 1/1/2011
The FAST: A Brief , Practical, Comprehensive, Valid, Functional Assessment for Alzheimer's Disease (AD) Staging, Diagnosis, and Differential Diagnosis in the Primary C...
Reisberg, B., Wegiel, J., Franssen, E., Montiero, I., Torossian, C., Anwar, S., Gill, T., Boksay, I., Auer, S., Shimala, M., Meguro, K., Alzheimer's & Dementia, 1/1/2011
Impact of Hormone Replacement Therapy (HRT) Usage on 7 Year Outcome of Older Persons with Subjective Cognitive Impairment
Reisberg, B., Osorio, R., Torossian, C., Janisar, M., Lobach, I., Joseph, P., Monteiro, I., Gill, T., and Khan, A., Alzheimer's & Dementia, 1/1/2011
Relating Memory to Functional Capacity from Normal Aging to Dementia Using Hierarchical Bayesian Cognitive Processing Models
Shankle, W., Pooley, J., Steyvers, M., Hara, J., Reisberg, B., and Lee, M., Alzheimer's & Dementia, 1/1/2011
IPA Testamentary Capacity Taskforce Mock Trial II
Peisah, C., Finkel, S., Firmino, H., Gauthier, S., Luxenberg, J., and Reisberg, B., International Psychogeriatrics, 1/1/2011
An Alzheimer's Disease International and Alzheimer's Netherlands Symposium, Assessment and Outcome of Older Subjects with Subjective Cognitive Impairment (SCI) and No ...
Reisberg, B., Shulman, M., Khan, A., Gill, T., and Osorio, R., International Psychogeriatrics, 1/1/2011
An Alzheimer's Disease International and Alzheimer's Netherlands Symposium, Clinical Methodologies for the Identification and Assessment of Subjective Cognitive Impair...
Reisberg, B. and Verhey, F., International Psychogeriatrics, 1/1/2011
Clinical Assessment Methodology for Alzheimer's Disease Prevention Trials: A Global and Multi-axial 2 Year Study of Pre-mild Cognitive Impairment (Pre-MCI) Subjective ...
Reisberg, B., Osorio, R., Khan, A., Roy, K., Torossian, C., Monteiro, I., Anwar, S., Shulman, M.B., and Lobach, I., Neuropsychopharmacology, 1/1/2011
The Prevention Working Group of Alzheimer's Disease International (ADI): Current Possibilities for the Prevention of Alzheimer's Disease
Reisberg, B., 25th International Conference of Alzheimer's Disease International (ADI), 1/1/2010
An Electrophysiological Model of Retrogenesis
Borza, L.R., Reisberg, B., and Astarastoae, V., 25th International Conference of Alzheimer's Disease International (ADI), 1/1/2010
Retrogenesis: Evidence from Brain Development
Borza, L.R., Reisberg, B., and Astarastoae, V., 25th International Conference of Alzheimer's Disease International (ADI), 1/1/2010
Which Comes First: Subjective Cognitive Impairment (SCI) Or Cognitive Change? And Is SCI a Frequently Occurring Stage in the Evolution of Alzheimer- Associated Cogniti...
Reisberg, B., Shulman, M.B., Torossian, C., Boksay, I., Khan, S., and Zhu, W., Alzheimer's & Dementia, 1/1/2010
The Pre-mild Cognitive Impairment, Subjective Cognitive Impairment Stage of Eventual Alzheimer's Disease (AD): An Opportunity for Treatment More than Twenty Years befo...
Reisberg, B., Shulman, M.B., Prichep, L., Mosconi, L., Zhu, W., Convit, A., and de Leon, M.J., 13th Asia-Pacific Regional Conferences of Alzheimer's Disease International, Programme and Abstracts Handbook, 1/1/2010
Join now to see all

Lectures

Novel and Emerging Aspects of Brain Aging and Alzheimer's Disease: Part 1: "Subjective Cognitive Impairment (SCI), The Pre-MCI Stage of Alzheimer's Disease: Antecedent...
Iasi, Romania - 1/27/2012
"Subject Interview and Final Discussion," in "Workshop on Methodologies for Clinical Trials in Pre-MCI Persons with Subjective Cognitive Impairment (SCI)"
Toronto, Canada - 1/26/2011
Treatment of Alzheimer's Disease: Function," in "Alzheimer's Disease in Primary Care Settings
Paris, France. - 1/16/2011
"Expert Witness," in "IPA Testamentary Capacity Taskforce Mock Trial II"
The Hague, The Netherlands. - 1/6./2011
Pri-Med Institute, "Recognizing, Diagnosing, and Treating Alzheimer's Disease"
Jacob K. Javitz Convention Center, New York, New York - 1/27/2009
Toward a Rational Polypharmacy for Cognitive Impairment
The New York Academy of Medicine, New York, New York - 1/1/2004
Retrogenesis: Life's Mirror: A New Way of Understanding and Treating Alzheimer's Disease
New York, New York - 1/1/2004
Medical Update: Diagnosis and Treatment
New York, New York - 1/1/2004
Current Treatments and Understanding of Dementia
Evanston Northwestern Healthcare, Evanston, Illinois - 1/1/2004
Memantine in the Treatment Alzheimer's
Boston, Massachusetts - 1/1/2004
R: "A Controversial Issue or Therapeutic Approach?
Chicago, Illinois. - 1/17/2003
Life's Mirror: Understanding and Treating Alzheimer's Disease
New York, New York - 1/1/2003
The Memantine Story
New York, New York - 1/1/2003
Mild Cognitive Impairment
Stamford, Connecticut - 1/1/2003
Research Update
New York, New York - 1/1/2003
The Staging of Alzheimer's Disease
Miami, Florida - 1/1/2003
Plenary Presentation: The Memantine Story
New York, New York - 1/1/2003
Workshop: Pharmacology of Alzheimer's Disease
New York, New York - 1/1/2003
New Treatments for Alzheimer's Disease
The Jewish Home & Hospital Lifecare System, Sarah Neuman Center for Healthcare & Rehabilitation, ama - 1/1/2003
Retrogenesis: A New Science of Alzheimer's Disease Management
New York, New York - 1/1/2002
Ebixa - In Moderate to Severe AD
Huatulco, Oaxaca, Mexico - 1/1/2002
Clinical Endpoints in Diagnosis and Evaluation of Alzheimer's Disease
Stockholm, Sweden - 1/1/2002
"Long-term Treatment with the NMDA Antagonist, Memantine: Results of a 24 Week Open Label Extension Study in Advanced Alzheimer's Disease
Waikaloa, Hawaii - 1/9./2001
New Horizons in Alzheimer's Disease
Gatlinburg, Tennessee - 1/1/2001
Assessment and Management of Alzheimer's and Dementia Patients
Lincoln, Nebraska - 1/1/2001
Join now to see all

Other

BEHAVE-AD
Barry Reisberg, M.D.
1/1/2008
Documental Alzheimer, directed by Eduardo Antoja
Fundacion Ala Caixa
Barcelona, Spain - 1/1/2004
Clinical Experience with Ebixa in Moderate to Severe AD [via videoconference from New York, New York]
Ebixa Launch Symposium
Thessalonika, Greece, 2003; Athens, Greece, 2003 - 1/1/2003
Medical Update, a Pill for Alzheimer's
Readers Digest
1/1/2003
Une retombee en enfance?
Blond, O., La Recherche
1/1/2003
The Forgetting: Alzheimer's: Portrait of an Epidemic
Shenk, D., Doubleday
1/1/2001
Preventing Good Brains from Going Bad
Schmeideskamp, M., Scientific American Presents
1/1/2000
Alzheimer's Research Hits New Highs
Provider
1/1/2000
Caregiving: A Scientific Profile for Dementia Care
Wagner, L., Provider
1/1/2000
BPSD and the Psychosis of AD: Treatment Possibilities.
Reisberg, B., Psychopharmacologic Drugs Advisory Committee, Food and Drug Administration, US DHHS
http://www.fda.gov/ohrms/dockets/ac/acmenu.htm
1/1/2000
Chat with Dr. Barry Reisberg, All About Alzheimer's
ABCNEWS.com
http://abcnews.go.com/sections/living/chats/alzheimers.html
1/1/1998
Coping with Alzheimer's
Hochman, G., Reader's Digest
1/1/1986
Alzheimer's Disease: A Clinical Update
Barry Reisberg, M.D., Network for Continuing Medical Education (NCME)
Secaucus, NJ - 1/1/1984
Alzheimer's Disease: Clinical Recognition, Diagnosis, Staging and Management
Barry Reisberg, M.D., Network for Continuing Medical Education (NCME)
Secaucus, NJ - 1/1/1984
Coming Full Circle
Leland, J., The New York Times
1/2./2008
Interview with Dr. Reisberg
AMA Radio News
1/28/2000
Drug Cocktail May Slow Alzheimer's
Johannes, L., The Wall Street Journal
http://online.wsj.com/article/SB123603689949914421.html
1/3./2009
Subjective Cognitive Impairment Early Indicator of Future Cognitive Deficits
Anderson, P., Medscape Medical News
1/14/2010
Increased Risk for MCI and Dementia Seen in Healthy Older Adults with Subjective Memory Loss
Eurekalert, MeD India
1/15/2010
People with Subjective Memory Loss at Increased Risk of Dementia

DNAINDIA.COM
1/9./2010
Many Alzheimer's Patients Find Comfort in Books, the New Old Age: Caring And Coping
Freudenheim, Milt, New York Times
http://newoldage.blogs.nytimes.com/2010/04/22/many-alzheimers-patients-find-comfort-in-books/
1/22/2010
When Lapses are Not Just Signs of Aging
Brody, Jane E., New York Times
1/5./2011
Until There is a Cure: Non-Pharmacological Approaches to Dementia Care.
Jed Levine interviews Barry Reisberg, M.D.
Doctor Radio, Interview with Dr. Reisberg
Sirius Satellite Radio
1/1./2008
The John Gambling Show
WABC (New York)
1/8./2004
Join now to see all

Press Mentions

St. Luke’s Health-Memorial, Baylor College of Medicine Establish New Rural Health Residency ProgramOctober 8th, 2022
How Alzheimer's Disease Progresses: From Diagnosis Through the 7 StagesAugust 22nd, 2022
7 Stages of Alzheimer’s Disease…and Related DementiaApril 9th, 2020
Join now to see all

Grant Support

Institutionalization of Alzheimer's disease patients: precipitating factors and effects of intervention and counselingAARP Andrus Foundation1984–Present
A proof of concept study fo the prevention of mild cognitive impairment and eventual Alzheimer's diseaseThe Stringer Foundation2011–2018
Clinical Researcher Development Fund of the New York University School of MedicineNew York University School of Medicine2013–2017
Alzheimer's Research under the direction of Barry Reisberg, M.D.The Louis J. Kay and June E. Kay Foundation2011–2017
Alzheimer's Research under the direction of Barry Reisberg, M.D. and Steven Ferris, Ph.D.The Hagedorn Fund2006–2017
The Zachary and Elizabeth M. Fisher Education and Resources Program at the New York University School of MedicineThe Zachary and Elizabeth M. Fisher Center for Alzheimer's Research Foundation2008–2016
Alzheimer's Disease Prevention and TreatmentThe Woodburne Foundation2008–2012
Clinical Core (And Smp)National Institute On Aging2010
Clinical CoreNational Institute On Aging2005–2009
Alzheimer's Research under the direction of Dr. Barry ReisbergThe Leonard Litwin Fund for Alzheimer's Disease Research2004–2009
Aging And Dementia Longitudinal Course Of SubgroupsNational Center For Research Resources2004–2008
The Zachary and Elizabeth M. Fisher Center for Alzheimer's Research FoundationZachary and Elizabeth M. Fisher Medical Foundation, in association with the U.S. DHHS Administration on Aging1998–2007
Aging And Dementia--Longitudinal Course Of SubgroupsNational Institute On Aging1997–2002
Core--ClinicalNational Institute On Aging1996–2002
Zachary and Elizabeth M. Fisher Alzheimer's Disease Education and Resources Program of the New York University Medical CenterZachary and Elizabeth M. Fisher Medical Foundation1995–1998
Core--ClinicalNational Institute On Aging1995–1996
Aging And Dementia--Longitudinal StudyNational Institute On Aging1995–1996
Behavioral And Psychotic Symptoms In Alzheimers DiseaseNational Institute On Aging1994
Aging And Dementia--Longitudinal StudyNational Institute On Aging1994
Non-Pharmacologic Modifications Of Behavior In ADNational Institute On Aging1992–1994
Core--Clinical Assessment And TrackingNational Institute On Aging1990–1994
Aging And Dementia: Longitudinal Course Of SubgroupsNational Institute On Aging1993
Behavioral And Psychotic Symptoms In Alzheimer'S DiseaseNational Institute On Aging1990–1993
Aging And Dementia--Longitudinal Course Of SubgroupsNational Institute On Aging1992
Aging And Dementia: Longitudinal Course Of SubgroupsNational Institute On Aging1987–1991
Phenomenology and Pharmacologic Remediation of Psychotic and Psychosis-like Symptomatology in Alzheimer's DiseaseBeckman Research Institute of the City of Hope and the Hurd Foundation1984–1985
Naloxone treatment of primary degenerative dementiaThe Nina M. Werblow Charitable Trust1982–1984

Committees

Medical and Scientific Advisory Panel, Alzheimer's Disease International 1997 - Present
Scientific Advisory Board, Maria Wolff Foundation, Madrid, Spain 2014 - 2014
Awards Selection Committee, Annual Research Day, New York University Medical Center, The Comprehensive Center on Brain Aging and Silberstein Alzheimer's Institute 2012 - 2013
Steering Committee, New York University Medical Center, Comprehensive Center on Brain Aging 2012 - 2013
Competition Committee for the position of Director of the Council of Doctoral Studies, Romania Education Ministry, University of Medicine and Pharmacy, Gr. T. Popa, Iasi 2012 - 2012
Center of Excellence on Brain Aging Seed Grant Review Committee, New Yok University Langone Medical Center, Center of Excellence on Brain Aging, Office of Science and Research 2012 - 2012
Pilot Study Review Committee, New York University School of Medicine, Alzheimer's Disease Center 2011 - 2011
Global Scientific Committee, Wisdem: Understanding Dementia, Improving Quality of Life 2011 - 2011
Director, Scientific Colloquium Series, New York University School of Medicine, Alzheimer's Disease Center 2010 - 2011
Steering Committee, New York University School of Medicine, Center of Excellence on Brain Aging 2009 - 2012
International Scientifice Committee, 8th Congress of the International Society for the Amelioration of the Quality of Life, Delphi, Greece 2009 - 2010
Chairman, Prevention Working Group, Alzheimer's Disease International 2008 - 2017
Appointments and Promotions Committee, New York University School of Medicine, Department of Psychiatry 2008 - 2013
Chairman, Retrospective Review of Testamentary Capacity Subgroup of the Task Force on Testametary Capacity, International Psychogeriatric Association 2008 - 2011
International Advisory Board, 25th International Conference of Alzheimer's Disease International, Thessaloniki, Greece 2008 - 2010
Scientific Program Committee, 23rd Alzheimer's Disease International Conference, Caracus, Venezuela 2006 - 2007
Advisory Committee, IV Neuroforum Dementia Conference, Barcelona, Spain 2006 - 2006
Scientific Program Committee, 12th Congress, International Psychogeriatric Association 2005 - 2005
Advisory Committee, Neuroforum Dementia, Barcelona, Spain 2005 - 2005
International Scientific Committee, 3rd International Congress on the Improvement of the Quality of Life in Dementia, Epilepsy, and MS, Alexandria, Egypt 2004 - 2005
Advisory Committee, Neuroforum Dementia, Barcelona, Spain 2003 - 2004
Task Force on Dementia, World Federation of Societies of Biological Psychiatry 2002 - 2017
Advisory Board, Morbus Alzheimer Society, Bad Ischl, Austria 2002 - 2017
Scientific Executive Committee, New York University School of Medicine, William and Silvia Silberstein Institute for Aging and Dementia 2002 - 2009
Professional Advisory Committee, Alzheimer's Disease and Related Disorders Inc., New York City Chapter 2002 - 2006
Scientific Program Committee, 9th International Conference on Alzheimer's Disease and Related Disorders, Philadelphia, PA 2002 - 2004
Board of Directors, New York University School of Medicine, William and Silvia Silberstein Institute for Aging and Dementia 2001 - 2006
Co-Convener, International Conference, From Retrogenesis to Cognitive Intervention in Alzheimer's Disease, Barcelona, Spain 2001 - 2001
Organizing Committee, 11th International Psychogeriatric Association International Congress 2001 - 2001
Ethics Committee, International College of Geriatric Psychopharmacology 2001 - 2001
International Consultant, Alzheimer's Disease and Dementia Initiative, Invitational Planning Symposium, Government of Alberta, Department of Health and Wellness, Edmonton, Alberta, Canada 2001 - 2001
Scientific Advisory Council, World Alzheimer Congress 2000 - 2000
Congress Scientific Committee, Regional Congress of Biological Psychiatry, Istanbul, 2000, Istanbul, Turkey 2000 - 2000
International Scientific Advisory Committee, 2nd Bologna International Meeting on Cognitive, Affective and Behavioral Disorders in the Elderly, Bologna, Italy 2000 - 2000
Consultant, Psychopharmacologic Drugs Advisory Committee, Food and Drug Adminstration (USA) 2000 - 2000
Research Committee, New York University School of Medicine, Department of Psychiatry 1999 - 2008
Past President, International Psychogeriatric Association 1999 - 2001
Chairman, Publications Committee, International Psychogeriatric Association 1999 - 2001
Work Group on Women and Alzheimer's Disease, Ronald and Nancy Reagan Research Institute, Alzheimer's Association 1998 - 1998
President, International Psychogeriatric Association 1997 - 1999
Chairman, International Working Group of Harmonization of Dementia Drug Guidelines, Clinical Global Committee 1995 - 2005
President-Elect, Internatinoal Psychogeriatric Association 1995 - 1997
International Research Advisory Board, WHO Project on Development of Methodologies for early Diagnosis, Prevention and Treatment of Alzheimer's Disease 1995 - 1995
Chairman, International ADL Project sponsored by Bayer AG 1993 - 2001
Medical and Scientific Advisory Board, Alzheimer's Association (USA) 1993 - 1997
Treasurer, Internatinoal Psychogeriatric Association 1993 - 1995
Research Committee, American Association for Geriatric Psychiatry 1992 - 1999
Board of Directors, American Association for Geriatric Psychiatry 1992 - 1996
Secretary, American Association for Geriatric Psychiatry 1991 - 1992
Executive Committee, New York University School of Medicine, NYU Alzheimer's Disease Center 1990 - 2017
National Institutes of Health Reviewers Reserve, National Institutes of Health 1990 - 1994
Contributor, Delirium, Dementia and Amnestic and other Cognitive Disorder Advisor, Work Group, Diagnostic and Statistic Manual of Mental Disorders: 4th Edition (DSM-IV), American Psychiatric Association 1990 - 1994
Board of Directors, American Aging Association 1990 - 1992
Chairman, Pharmacy and Therapeutics Committee, International Psychogeriatric Association 1989 - 2003
Ad Hoc FDA Dementia Assessment Task Force, Division of Neuropsychopharmacological Drug Products Peripheral and Central Nervous System Advisory Committee, Food and Drug Administration (USA) 1989 - 1989
International Scientific Advisory Committee, International Conferences on Alzheimer's Disease and Related Disorders 1988 - 2006
Chairman, Research Awards Committee, Internatinoal Psychogeriatric Association 1988 - 2003
Professional Advisory Committee, New York Department of Housing Preservation and Development 1987 - 1987
Grant Reviewer for the NIH, Human Development and Aging Study Section, Division of Research Grants, National Institutes of Health 1986 - 1990
Research Advisory Board, National Center for Homecare, Education and Research 1986 - 1988
American Psychiatric Association Delegate, The 1981 White House Conference on Aging to 1986: a Mid-Decade Review 1986 - 1986
Board of Directors, Internatinoal Psychogeriatric Association 1985 - 1993
Research Advisory Board, Visiting Nurse Service of New York 1985 - 1985
Institute on Alzheimer's Disease and Related Disorders, New York Academy of Medicine and New York State Health Planning Commission 1984 - 1987
Advisory Board, Alzheimer's Disease Center, New York City Department for the Aging 1984 - 1986
Program Committee, American Association for Geriatric Psychiatry 1984 - 1985
Chairman, Workgroup on Drugs and Cerebral Function, World Health Organization 1984 - 1984
Planning Committee, Mayoral Conference on Alzheimer's Disease, New York City Department for the Aging 1983 - 1983
Examiner, American Board of Psychiatry and Neurology 1983 - 1983
Task Force to Develop a Curriculum in Geriatric Psychiatry, American Psychiatric Association 1982 - 1983
Chairman, Awards Committe, American Association for Geriatric Psychiatry 1980 - 1981